Alterations in genes connected to telomere maintenance (i.e., TERT and ATRX) have recently been shown to be recurrent in non-MYCN-amplified NBs, which are also connected to adverse outcome12. This evidence concerns the gene MYCN and Nijmegen breakage syndrome.